BIIB
Biogen Inc
Price:  
211.17 
USD
Volume:  
2,255,736.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biogen WACC - Weighted Average Cost of Capital

The WACC of Biogen Inc (BIIB) is 8.6%.

The Cost of Equity of Biogen Inc (BIIB) is 9.55%.
The Cost of Debt of Biogen Inc (BIIB) is 4.55%.

Range Selected
Cost of equity 8.20% - 10.90% 9.55%
Tax rate 13.90% - 16.80% 15.35%
Cost of debt 4.00% - 5.10% 4.55%
WACC 7.3% - 9.8% 8.6%
WACC

Biogen WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.93 1.08
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.20% 10.90%
Tax rate 13.90% 16.80%
Debt/Equity ratio 0.21 0.21
Cost of debt 4.00% 5.10%
After-tax WACC 7.3% 9.8%
Selected WACC 8.6%